Literature DB >> 11863413

Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.

Hideki Hanawa1, Patrick F Kelly, Amit C Nathwani, Derek A Persons, Jody A Vandergriff, Phillip Hargrove, Elio F Vanin, Arthur W Nienhuis.   

Abstract

Substantial effort has been invested in developing methodologies for efficient gene transfer into human, repopulating, hematopoietic stem cells. Oncoretroviral vectors are limited by the lack of nuclear mitosis in quiescent stem cells during ex vivo transduction, whereas the preintegration complex of lentiviral vectors contains nuclear-localizing signals that permit genome integration without mitosis. We have developed a flexible and versatile system for generating lentiviral vector particles and have pseudotyped such particles with amphotropic, ecotropic, feline endogenous virus (RD114) or vesicular stomatitis virus (VSV-G) envelope proteins. Particles of all four types could be concentrated approximately 100-fold by ultracentrifugation or ultrafiltration. RD114 or amphotropic particles were more efficient than VSV-G-pseudotyped particles at transducing human cord blood CD34(+) cells and clonogenic progenitors within that population. Amphotropic particles transduced cytokine-mobilized, human peripheral blood CD34(+) cells capable of establishing hematopoiesis in immunodeficient mice more efficiently than the other two types of particles. We conclude that the use of amphotropic pseudotyped lentiviral vector particles rather than the commonly used VSV-G-pseudotyped particles should be considered in potential applications of lentiviral vectors for gene transfer into this therapeutically relevant target cell population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863413     DOI: 10.1006/mthe.2002.0549

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  78 in total

1.  Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Authors:  Michael D Mühlebach; Isabel Schmitt; Stefanie Steidl; Jörn Stitz; Matthias Schweizer; Thomas Blankenstein; Klaus Cichutek; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2003-10-24       Impact factor: 4.599

2.  Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.

Authors:  Yoon-Sang Kim; Matthew M Wielgosz; Phillip Hargrove; Steven Kepes; John Gray; Derek A Persons; Arthur W Nienhuis
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

3.  Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.

Authors:  Lucas Chan; Darren Nesbeth; Taylor Mackey; Joanna Galea-Lauri; Joop Gäken; Francisco Martin; Mary Collins; Ghulam Mufti; Farzin Farzaneh; David Darling
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Authors:  Hideki Hanawa; Derek A Persons; Arthur W Nienhuis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

6.  CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.

Authors:  Colin L Sweeney; Uimook Choi; Chengyu Liu; Sherry Koontz; Seung-Kwon Ha; Harry L Malech
Journal:  Hum Gene Ther       Date:  2017-03-06       Impact factor: 5.695

7.  RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells.

Authors:  Naoya Uchida; Kareem N Washington; Brian Mozer; Charlotte Platner; Josiah Ballantine; Luke P Skala; Lydia Raines; Anna Shvygin; Matthew M Hsieh; Lloyd G Mitchell; John F Tisdale
Journal:  Hum Gene Ther Methods       Date:  2017-02-14       Impact factor: 2.396

8.  Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Authors:  Chi-Ping Day; John Carter; Carrie Bonomi; Dominic Esposito; Bruce Crise; Betty Ortiz-Conde; Melinda Hollingshead; Glenn Merlino
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-19       Impact factor: 4.693

Review 9.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

10.  Kinetics of lentiviral vector transduction in human CD34(+) cells.

Authors:  Naoya Uchida; Rashidah Green; Josiah Ballantine; Luke P Skala; Matthew M Hsieh; John F Tisdale
Journal:  Exp Hematol       Date:  2015-10-21       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.